nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CA2—osteoporosis	0.378	1	CbGaD
Dorzolamide—CA14—Zoledronate—osteoporosis	0.147	0.345	CbGbCtD
Dorzolamide—CA12—Zoledronate—osteoporosis	0.104	0.245	CbGbCtD
Dorzolamide—CA2—Zoledronate—osteoporosis	0.0842	0.198	CbGbCtD
Dorzolamide—CYP2C9—Estropipate—osteoporosis	0.0175	0.0412	CbGbCtD
Dorzolamide—CYP3A4—Estropipate—osteoporosis	0.0102	0.0239	CbGbCtD
Dorzolamide—CYP3A4—Calcitriol—osteoporosis	0.0102	0.0239	CbGbCtD
Dorzolamide—CYP2C9—Cholecalciferol—osteoporosis	0.00901	0.0212	CbGbCtD
Dorzolamide—CYP3A4—Ergocalciferol—osteoporosis	0.00813	0.0191	CbGbCtD
Dorzolamide—CYP2C9—Estradiol—osteoporosis	0.00726	0.0171	CbGbCtD
Dorzolamide—CYP3A4—Raloxifene—osteoporosis	0.00678	0.016	CbGbCtD
Dorzolamide—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00655	0.0154	CbGbCtD
Dorzolamide—CYP3A4—Cholecalciferol—osteoporosis	0.00524	0.0123	CbGbCtD
Dorzolamide—CYP3A4—Conjugated Estrogens—osteoporosis	0.00481	0.0113	CbGbCtD
Dorzolamide—CYP3A4—Estradiol—osteoporosis	0.00422	0.00994	CbGbCtD
Dorzolamide—Brinzolamide—CA2—osteoporosis	0.00338	1	CrCbGaD
Dorzolamide—Syncope—Zoledronate—osteoporosis	0.000127	0.000979	CcSEcCtD
Dorzolamide—Anaphylactic shock—Pamidronate—osteoporosis	0.000126	0.000976	CcSEcCtD
Dorzolamide—Oedema—Pamidronate—osteoporosis	0.000126	0.000976	CcSEcCtD
Dorzolamide—Urticaria—Calcitriol—osteoporosis	0.000125	0.000969	CcSEcCtD
Dorzolamide—Palpitations—Zoledronate—osteoporosis	0.000125	0.000965	CcSEcCtD
Dorzolamide—Abdominal pain—Calcitriol—osteoporosis	0.000125	0.000964	CcSEcCtD
Dorzolamide—Body temperature increased—Calcitriol—osteoporosis	0.000125	0.000964	CcSEcCtD
Dorzolamide—Angioedema—Conjugated Estrogens—osteoporosis	0.000124	0.000961	CcSEcCtD
Dorzolamide—Shock—Pamidronate—osteoporosis	0.000124	0.00096	CcSEcCtD
Dorzolamide—Loss of consciousness—Zoledronate—osteoporosis	0.000124	0.00096	CcSEcCtD
Dorzolamide—Pharyngitis—Estradiol—osteoporosis	0.000124	0.000959	CcSEcCtD
Dorzolamide—Hypersensitivity—Estropipate—osteoporosis	0.000124	0.000957	CcSEcCtD
Dorzolamide—Vomiting—Etidronic acid—osteoporosis	0.000124	0.000955	CcSEcCtD
Dorzolamide—Cough—Zoledronate—osteoporosis	0.000123	0.000953	CcSEcCtD
Dorzolamide—Rash—Etidronic acid—osteoporosis	0.000123	0.000947	CcSEcCtD
Dorzolamide—Dermatitis—Etidronic acid—osteoporosis	0.000122	0.000946	CcSEcCtD
Dorzolamide—Vertigo—Conjugated Estrogens—osteoporosis	0.000122	0.000945	CcSEcCtD
Dorzolamide—Hyperhidrosis—Pamidronate—osteoporosis	0.000122	0.000943	CcSEcCtD
Dorzolamide—Syncope—Conjugated Estrogens—osteoporosis	0.000122	0.000943	CcSEcCtD
Dorzolamide—Hypertension—Zoledronate—osteoporosis	0.000122	0.000943	CcSEcCtD
Dorzolamide—Hypersensitivity—Alendronate—osteoporosis	0.000122	0.000942	CcSEcCtD
Dorzolamide—Headache—Etidronic acid—osteoporosis	0.000122	0.00094	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000121	0.000935	CcSEcCtD
Dorzolamide—Asthenia—Estropipate—osteoporosis	0.000121	0.000932	CcSEcCtD
Dorzolamide—Visual impairment—Estradiol—osteoporosis	0.000121	0.000932	CcSEcCtD
Dorzolamide—Anorexia—Pamidronate—osteoporosis	0.00012	0.00093	CcSEcCtD
Dorzolamide—Arthralgia—Zoledronate—osteoporosis	0.00012	0.00093	CcSEcCtD
Dorzolamide—Chest pain—Zoledronate—osteoporosis	0.00012	0.00093	CcSEcCtD
Dorzolamide—Palpitations—Conjugated Estrogens—osteoporosis	0.00012	0.000929	CcSEcCtD
Dorzolamide—Insomnia—Risedronate—osteoporosis	0.00012	0.000928	CcSEcCtD
Dorzolamide—Anxiety—Zoledronate—osteoporosis	0.00012	0.000926	CcSEcCtD
Dorzolamide—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00012	0.000924	CcSEcCtD
Dorzolamide—Paraesthesia—Risedronate—osteoporosis	0.000119	0.000922	CcSEcCtD
Dorzolamide—Pruritus—Estropipate—osteoporosis	0.000119	0.000919	CcSEcCtD
Dorzolamide—Discomfort—Zoledronate—osteoporosis	0.000119	0.000919	CcSEcCtD
Dorzolamide—Asthenia—Alendronate—osteoporosis	0.000119	0.000918	CcSEcCtD
Dorzolamide—Hypersensitivity—Ibandronate—osteoporosis	0.000119	0.000918	CcSEcCtD
Dorzolamide—Cough—Conjugated Estrogens—osteoporosis	0.000119	0.000918	CcSEcCtD
Dorzolamide—Dyspnoea—Risedronate—osteoporosis	0.000119	0.000915	CcSEcCtD
Dorzolamide—Erythema multiforme—Estradiol—osteoporosis	0.000118	0.000914	CcSEcCtD
Dorzolamide—Hypotension—Pamidronate—osteoporosis	0.000118	0.000912	CcSEcCtD
Dorzolamide—Dry mouth—Zoledronate—osteoporosis	0.000118	0.000909	CcSEcCtD
Dorzolamide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000118	0.000908	CcSEcCtD
Dorzolamide—Pruritus—Alendronate—osteoporosis	0.000117	0.000905	CcSEcCtD
Dorzolamide—Dyspepsia—Risedronate—osteoporosis	0.000117	0.000903	CcSEcCtD
Dorzolamide—Tinnitus—Estradiol—osteoporosis	0.000117	0.000901	CcSEcCtD
Dorzolamide—Confusional state—Zoledronate—osteoporosis	0.000116	0.000899	CcSEcCtD
Dorzolamide—Hypersensitivity—Calcitriol—osteoporosis	0.000116	0.000898	CcSEcCtD
Dorzolamide—Chest pain—Conjugated Estrogens—osteoporosis	0.000116	0.000895	CcSEcCtD
Dorzolamide—Arthralgia—Conjugated Estrogens—osteoporosis	0.000116	0.000895	CcSEcCtD
Dorzolamide—Asthenia—Ibandronate—osteoporosis	0.000116	0.000894	CcSEcCtD
Dorzolamide—Anxiety—Conjugated Estrogens—osteoporosis	0.000116	0.000892	CcSEcCtD
Dorzolamide—Nausea—Etidronic acid—osteoporosis	0.000115	0.000892	CcSEcCtD
Dorzolamide—Oedema—Zoledronate—osteoporosis	0.000115	0.000891	CcSEcCtD
Dorzolamide—Anaphylactic shock—Zoledronate—osteoporosis	0.000115	0.000891	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000115	0.000889	CcSEcCtD
Dorzolamide—Diarrhoea—Estropipate—osteoporosis	0.000115	0.000889	CcSEcCtD
Dorzolamide—Fatigue—Risedronate—osteoporosis	0.000115	0.000885	CcSEcCtD
Dorzolamide—Insomnia—Pamidronate—osteoporosis	0.000114	0.000882	CcSEcCtD
Dorzolamide—Pruritus—Ibandronate—osteoporosis	0.000114	0.000881	CcSEcCtD
Dorzolamide—Pain—Risedronate—osteoporosis	0.000114	0.000878	CcSEcCtD
Dorzolamide—Shock—Zoledronate—osteoporosis	0.000114	0.000877	CcSEcCtD
Dorzolamide—Paraesthesia—Pamidronate—osteoporosis	0.000113	0.000876	CcSEcCtD
Dorzolamide—Diarrhoea—Alendronate—osteoporosis	0.000113	0.000875	CcSEcCtD
Dorzolamide—Asthenia—Calcitriol—osteoporosis	0.000113	0.000875	CcSEcCtD
Dorzolamide—Dyspnoea—Pamidronate—osteoporosis	0.000113	0.00087	CcSEcCtD
Dorzolamide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000112	0.000867	CcSEcCtD
Dorzolamide—Somnolence—Pamidronate—osteoporosis	0.000112	0.000867	CcSEcCtD
Dorzolamide—Pruritus—Calcitriol—osteoporosis	0.000112	0.000863	CcSEcCtD
Dorzolamide—Hyperhidrosis—Zoledronate—osteoporosis	0.000112	0.000862	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000111	0.000861	CcSEcCtD
Dorzolamide—Diarrhoea—Raloxifene—osteoporosis	0.000111	0.000861	CcSEcCtD
Dorzolamide—Dyspepsia—Pamidronate—osteoporosis	0.000111	0.000859	CcSEcCtD
Dorzolamide—Dizziness—Estropipate—osteoporosis	0.000111	0.000859	CcSEcCtD
Dorzolamide—Oedema—Conjugated Estrogens—osteoporosis	0.000111	0.000858	CcSEcCtD
Dorzolamide—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000111	0.000858	CcSEcCtD
Dorzolamide—Alopecia—Estradiol—osteoporosis	0.000111	0.000854	CcSEcCtD
Dorzolamide—Diarrhoea—Ibandronate—osteoporosis	0.00011	0.000852	CcSEcCtD
Dorzolamide—Anorexia—Zoledronate—osteoporosis	0.00011	0.00085	CcSEcCtD
Dorzolamide—Decreased appetite—Pamidronate—osteoporosis	0.00011	0.000848	CcSEcCtD
Dorzolamide—Dizziness—Alendronate—osteoporosis	0.00011	0.000846	CcSEcCtD
Dorzolamide—Shock—Conjugated Estrogens—osteoporosis	0.000109	0.000844	CcSEcCtD
Dorzolamide—Erythema—Estradiol—osteoporosis	0.000109	0.000842	CcSEcCtD
Dorzolamide—Fatigue—Pamidronate—osteoporosis	0.000109	0.000841	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Risedronate—osteoporosis	0.000109	0.000839	CcSEcCtD
Dorzolamide—Urticaria—Ethinyl Estradiol—osteoporosis	0.000108	0.000836	CcSEcCtD
Dorzolamide—Pain—Pamidronate—osteoporosis	0.000108	0.000834	CcSEcCtD
Dorzolamide—Diarrhoea—Calcitriol—osteoporosis	0.000108	0.000834	CcSEcCtD
Dorzolamide—Hypotension—Zoledronate—osteoporosis	0.000108	0.000833	CcSEcCtD
Dorzolamide—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000108	0.000832	CcSEcCtD
Dorzolamide—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000108	0.000832	CcSEcCtD
Dorzolamide—Dizziness—Raloxifene—osteoporosis	0.000108	0.000832	CcSEcCtD
Dorzolamide—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000107	0.00083	CcSEcCtD
Dorzolamide—Tension—Estradiol—osteoporosis	0.000107	0.000826	CcSEcCtD
Dorzolamide—Vomiting—Estropipate—osteoporosis	0.000107	0.000826	CcSEcCtD
Dorzolamide—Dysgeusia—Estradiol—osteoporosis	0.000107	0.000824	CcSEcCtD
Dorzolamide—Dizziness—Ibandronate—osteoporosis	0.000107	0.000824	CcSEcCtD
Dorzolamide—Rash—Estropipate—osteoporosis	0.000106	0.000819	CcSEcCtD
Dorzolamide—Dermatitis—Estropipate—osteoporosis	0.000106	0.000818	CcSEcCtD
Dorzolamide—Anorexia—Conjugated Estrogens—osteoporosis	0.000106	0.000818	CcSEcCtD
Dorzolamide—Nervousness—Estradiol—osteoporosis	0.000106	0.000817	CcSEcCtD
Dorzolamide—Urticaria—Risedronate—osteoporosis	0.000106	0.000815	CcSEcCtD
Dorzolamide—Back pain—Estradiol—osteoporosis	0.000105	0.000814	CcSEcCtD
Dorzolamide—Headache—Estropipate—osteoporosis	0.000105	0.000814	CcSEcCtD
Dorzolamide—Vomiting—Alendronate—osteoporosis	0.000105	0.000813	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000105	0.000812	CcSEcCtD
Dorzolamide—Abdominal pain—Risedronate—osteoporosis	0.000105	0.000811	CcSEcCtD
Dorzolamide—Body temperature increased—Risedronate—osteoporosis	0.000105	0.000811	CcSEcCtD
Dorzolamide—Rash—Alendronate—osteoporosis	0.000104	0.000807	CcSEcCtD
Dorzolamide—Insomnia—Zoledronate—osteoporosis	0.000104	0.000806	CcSEcCtD
Dorzolamide—Dermatitis—Alendronate—osteoporosis	0.000104	0.000806	CcSEcCtD
Dorzolamide—Feeling abnormal—Pamidronate—osteoporosis	0.000104	0.000804	CcSEcCtD
Dorzolamide—Hypotension—Conjugated Estrogens—osteoporosis	0.000104	0.000802	CcSEcCtD
Dorzolamide—Headache—Alendronate—osteoporosis	0.000104	0.000801	CcSEcCtD
Dorzolamide—Paraesthesia—Zoledronate—osteoporosis	0.000104	0.0008	CcSEcCtD
Dorzolamide—Vomiting—Raloxifene—osteoporosis	0.000104	0.0008	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Pamidronate—osteoporosis	0.000103	0.000798	CcSEcCtD
Dorzolamide—Dyspnoea—Zoledronate—osteoporosis	0.000103	0.000795	CcSEcCtD
Dorzolamide—Rash—Raloxifene—osteoporosis	0.000103	0.000793	CcSEcCtD
Dorzolamide—Dermatitis—Raloxifene—osteoporosis	0.000103	0.000792	CcSEcCtD
Dorzolamide—Somnolence—Zoledronate—osteoporosis	0.000103	0.000792	CcSEcCtD
Dorzolamide—Vomiting—Ibandronate—osteoporosis	0.000103	0.000792	CcSEcCtD
Dorzolamide—Headache—Raloxifene—osteoporosis	0.000102	0.000788	CcSEcCtD
Dorzolamide—Rash—Ibandronate—osteoporosis	0.000102	0.000785	CcSEcCtD
Dorzolamide—Dermatitis—Ibandronate—osteoporosis	0.000102	0.000785	CcSEcCtD
Dorzolamide—Dyspepsia—Zoledronate—osteoporosis	0.000102	0.000785	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000101	0.000782	CcSEcCtD
Dorzolamide—Headache—Ibandronate—osteoporosis	0.000101	0.00078	CcSEcCtD
Dorzolamide—Insomnia—Conjugated Estrogens—osteoporosis	0.000101	0.000776	CcSEcCtD
Dorzolamide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.0001	0.000776	CcSEcCtD
Dorzolamide—Vomiting—Calcitriol—osteoporosis	0.0001	0.000775	CcSEcCtD
Dorzolamide—Decreased appetite—Zoledronate—osteoporosis	0.0001	0.000775	CcSEcCtD
Dorzolamide—Nausea—Estropipate—osteoporosis	9.99e-05	0.000771	CcSEcCtD
Dorzolamide—Abdominal pain—Pamidronate—osteoporosis	9.99e-05	0.000771	CcSEcCtD
Dorzolamide—Body temperature increased—Pamidronate—osteoporosis	9.99e-05	0.000771	CcSEcCtD
Dorzolamide—Paraesthesia—Conjugated Estrogens—osteoporosis	9.98e-05	0.000771	CcSEcCtD
Dorzolamide—Angioedema—Estradiol—osteoporosis	9.96e-05	0.000769	CcSEcCtD
Dorzolamide—Rash—Calcitriol—osteoporosis	9.96e-05	0.000769	CcSEcCtD
Dorzolamide—Fatigue—Zoledronate—osteoporosis	9.95e-05	0.000768	CcSEcCtD
Dorzolamide—Dermatitis—Calcitriol—osteoporosis	9.95e-05	0.000768	CcSEcCtD
Dorzolamide—Dyspnoea—Conjugated Estrogens—osteoporosis	9.91e-05	0.000765	CcSEcCtD
Dorzolamide—Headache—Calcitriol—osteoporosis	9.89e-05	0.000764	CcSEcCtD
Dorzolamide—Somnolence—Conjugated Estrogens—osteoporosis	9.88e-05	0.000763	CcSEcCtD
Dorzolamide—Pain—Zoledronate—osteoporosis	9.87e-05	0.000762	CcSEcCtD
Dorzolamide—Nausea—Alendronate—osteoporosis	9.84e-05	0.00076	CcSEcCtD
Dorzolamide—Hypersensitivity—Risedronate—osteoporosis	9.79e-05	0.000756	CcSEcCtD
Dorzolamide—Vertigo—Estradiol—osteoporosis	9.79e-05	0.000756	CcSEcCtD
Dorzolamide—Dyspepsia—Conjugated Estrogens—osteoporosis	9.78e-05	0.000755	CcSEcCtD
Dorzolamide—Asthenia—Ethinyl Estradiol—osteoporosis	9.78e-05	0.000755	CcSEcCtD
Dorzolamide—Syncope—Estradiol—osteoporosis	9.77e-05	0.000755	CcSEcCtD
Dorzolamide—Nausea—Raloxifene—osteoporosis	9.68e-05	0.000747	CcSEcCtD
Dorzolamide—Decreased appetite—Conjugated Estrogens—osteoporosis	9.66e-05	0.000746	CcSEcCtD
Dorzolamide—Pruritus—Ethinyl Estradiol—osteoporosis	9.65e-05	0.000745	CcSEcCtD
Dorzolamide—Palpitations—Estradiol—osteoporosis	9.63e-05	0.000744	CcSEcCtD
Dorzolamide—Fatigue—Conjugated Estrogens—osteoporosis	9.58e-05	0.00074	CcSEcCtD
Dorzolamide—Nausea—Ibandronate—osteoporosis	9.58e-05	0.00074	CcSEcCtD
Dorzolamide—Loss of consciousness—Estradiol—osteoporosis	9.58e-05	0.00074	CcSEcCtD
Dorzolamide—Asthenia—Risedronate—osteoporosis	9.54e-05	0.000736	CcSEcCtD
Dorzolamide—Feeling abnormal—Zoledronate—osteoporosis	9.51e-05	0.000734	CcSEcCtD
Dorzolamide—Cough—Estradiol—osteoporosis	9.51e-05	0.000734	CcSEcCtD
Dorzolamide—Pain—Conjugated Estrogens—osteoporosis	9.5e-05	0.000734	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Zoledronate—osteoporosis	9.44e-05	0.000729	CcSEcCtD
Dorzolamide—Hypertension—Estradiol—osteoporosis	9.41e-05	0.000727	CcSEcCtD
Dorzolamide—Pruritus—Risedronate—osteoporosis	9.4e-05	0.000726	CcSEcCtD
Dorzolamide—Nausea—Calcitriol—osteoporosis	9.38e-05	0.000724	CcSEcCtD
Dorzolamide—Diarrhoea—Ethinyl Estradiol—osteoporosis	9.33e-05	0.00072	CcSEcCtD
Dorzolamide—Hypersensitivity—Pamidronate—osteoporosis	9.31e-05	0.000719	CcSEcCtD
Dorzolamide—Chest pain—Estradiol—osteoporosis	9.28e-05	0.000716	CcSEcCtD
Dorzolamide—Arthralgia—Estradiol—osteoporosis	9.28e-05	0.000716	CcSEcCtD
Dorzolamide—Anxiety—Estradiol—osteoporosis	9.25e-05	0.000714	CcSEcCtD
Dorzolamide—Urticaria—Zoledronate—osteoporosis	9.17e-05	0.000708	CcSEcCtD
Dorzolamide—Discomfort—Estradiol—osteoporosis	9.17e-05	0.000708	CcSEcCtD
Dorzolamide—Abdominal pain—Zoledronate—osteoporosis	9.12e-05	0.000705	CcSEcCtD
Dorzolamide—Body temperature increased—Zoledronate—osteoporosis	9.12e-05	0.000705	CcSEcCtD
Dorzolamide—Diarrhoea—Risedronate—osteoporosis	9.09e-05	0.000702	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	9.09e-05	0.000702	CcSEcCtD
Dorzolamide—Dry mouth—Estradiol—osteoporosis	9.07e-05	0.000701	CcSEcCtD
Dorzolamide—Asthenia—Pamidronate—osteoporosis	9.07e-05	0.0007	CcSEcCtD
Dorzolamide—Dizziness—Ethinyl Estradiol—osteoporosis	9.02e-05	0.000696	CcSEcCtD
Dorzolamide—Confusional state—Estradiol—osteoporosis	8.97e-05	0.000693	CcSEcCtD
Dorzolamide—Pruritus—Pamidronate—osteoporosis	8.94e-05	0.00069	CcSEcCtD
Dorzolamide—Oedema—Estradiol—osteoporosis	8.89e-05	0.000687	CcSEcCtD
Dorzolamide—Anaphylactic shock—Estradiol—osteoporosis	8.89e-05	0.000687	CcSEcCtD
Dorzolamide—Urticaria—Conjugated Estrogens—osteoporosis	8.83e-05	0.000682	CcSEcCtD
Dorzolamide—Dizziness—Risedronate—osteoporosis	8.79e-05	0.000679	CcSEcCtD
Dorzolamide—Abdominal pain—Conjugated Estrogens—osteoporosis	8.79e-05	0.000678	CcSEcCtD
Dorzolamide—Body temperature increased—Conjugated Estrogens—osteoporosis	8.79e-05	0.000678	CcSEcCtD
Dorzolamide—Shock—Estradiol—osteoporosis	8.75e-05	0.000676	CcSEcCtD
Dorzolamide—Vomiting—Ethinyl Estradiol—osteoporosis	8.67e-05	0.000669	CcSEcCtD
Dorzolamide—Diarrhoea—Pamidronate—osteoporosis	8.65e-05	0.000668	CcSEcCtD
Dorzolamide—Hyperhidrosis—Estradiol—osteoporosis	8.6e-05	0.000664	CcSEcCtD
Dorzolamide—Rash—Ethinyl Estradiol—osteoporosis	8.6e-05	0.000664	CcSEcCtD
Dorzolamide—Dermatitis—Ethinyl Estradiol—osteoporosis	8.59e-05	0.000663	CcSEcCtD
Dorzolamide—Headache—Ethinyl Estradiol—osteoporosis	8.54e-05	0.000659	CcSEcCtD
Dorzolamide—Hypersensitivity—Zoledronate—osteoporosis	8.5e-05	0.000657	CcSEcCtD
Dorzolamide—Vomiting—Risedronate—osteoporosis	8.45e-05	0.000653	CcSEcCtD
Dorzolamide—Rash—Risedronate—osteoporosis	8.38e-05	0.000647	CcSEcCtD
Dorzolamide—Dermatitis—Risedronate—osteoporosis	8.37e-05	0.000647	CcSEcCtD
Dorzolamide—Dizziness—Pamidronate—osteoporosis	8.36e-05	0.000645	CcSEcCtD
Dorzolamide—Headache—Risedronate—osteoporosis	8.33e-05	0.000643	CcSEcCtD
Dorzolamide—Asthenia—Zoledronate—osteoporosis	8.28e-05	0.000639	CcSEcCtD
Dorzolamide—Hypersensitivity—Conjugated Estrogens—osteoporosis	8.19e-05	0.000632	CcSEcCtD
Dorzolamide—Pruritus—Zoledronate—osteoporosis	8.17e-05	0.000631	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Estradiol—osteoporosis	8.1e-05	0.000626	CcSEcCtD
Dorzolamide—Nausea—Ethinyl Estradiol—osteoporosis	8.1e-05	0.000625	CcSEcCtD
Dorzolamide—Insomnia—Estradiol—osteoporosis	8.05e-05	0.000621	CcSEcCtD
Dorzolamide—Vomiting—Pamidronate—osteoporosis	8.03e-05	0.00062	CcSEcCtD
Dorzolamide—Paraesthesia—Estradiol—osteoporosis	7.99e-05	0.000617	CcSEcCtD
Dorzolamide—Asthenia—Conjugated Estrogens—osteoporosis	7.97e-05	0.000616	CcSEcCtD
Dorzolamide—Rash—Pamidronate—osteoporosis	7.97e-05	0.000615	CcSEcCtD
Dorzolamide—Dermatitis—Pamidronate—osteoporosis	7.96e-05	0.000615	CcSEcCtD
Dorzolamide—Dyspnoea—Estradiol—osteoporosis	7.93e-05	0.000612	CcSEcCtD
Dorzolamide—Headache—Pamidronate—osteoporosis	7.92e-05	0.000611	CcSEcCtD
Dorzolamide—Somnolence—Estradiol—osteoporosis	7.91e-05	0.000611	CcSEcCtD
Dorzolamide—Diarrhoea—Zoledronate—osteoporosis	7.9e-05	0.00061	CcSEcCtD
Dorzolamide—Nausea—Risedronate—osteoporosis	7.9e-05	0.00061	CcSEcCtD
Dorzolamide—Pruritus—Conjugated Estrogens—osteoporosis	7.86e-05	0.000607	CcSEcCtD
Dorzolamide—Dyspepsia—Estradiol—osteoporosis	7.83e-05	0.000605	CcSEcCtD
Dorzolamide—Decreased appetite—Estradiol—osteoporosis	7.73e-05	0.000597	CcSEcCtD
Dorzolamide—Fatigue—Estradiol—osteoporosis	7.67e-05	0.000592	CcSEcCtD
Dorzolamide—Dizziness—Zoledronate—osteoporosis	7.63e-05	0.000589	CcSEcCtD
Dorzolamide—Pain—Estradiol—osteoporosis	7.61e-05	0.000587	CcSEcCtD
Dorzolamide—Diarrhoea—Conjugated Estrogens—osteoporosis	7.6e-05	0.000587	CcSEcCtD
Dorzolamide—CA14—Metabolism—CYP27A1—osteoporosis	7.6e-05	0.00118	CbGpPWpGaD
Dorzolamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	7.51e-05	0.00116	CbGpPWpGaD
Dorzolamide—Nausea—Pamidronate—osteoporosis	7.51e-05	0.00058	CcSEcCtD
Dorzolamide—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	7.41e-05	0.00115	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CYP27A1—osteoporosis	7.4e-05	0.00115	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CYP27A1—osteoporosis	7.4e-05	0.00115	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PNP—osteoporosis	7.39e-05	0.00114	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ATIC—osteoporosis	7.39e-05	0.00114	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—ACP5—osteoporosis	7.39e-05	0.00114	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—IDH2—osteoporosis	7.35e-05	0.00114	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—IDH2—osteoporosis	7.35e-05	0.00114	CbGpPWpGaD
Dorzolamide—Dizziness—Conjugated Estrogens—osteoporosis	7.35e-05	0.000567	CcSEcCtD
Dorzolamide—Vomiting—Zoledronate—osteoporosis	7.34e-05	0.000567	CcSEcCtD
Dorzolamide—Feeling abnormal—Estradiol—osteoporosis	7.33e-05	0.000566	CcSEcCtD
Dorzolamide—CA9—Cellular responses to stress—GPX1—osteoporosis	7.32e-05	0.00113	CbGpPWpGaD
Dorzolamide—Rash—Zoledronate—osteoporosis	7.28e-05	0.000562	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Estradiol—osteoporosis	7.27e-05	0.000562	CcSEcCtD
Dorzolamide—Dermatitis—Zoledronate—osteoporosis	7.27e-05	0.000561	CcSEcCtD
Dorzolamide—Headache—Zoledronate—osteoporosis	7.23e-05	0.000558	CcSEcCtD
Dorzolamide—CA5A—Metabolism—ACP5—osteoporosis	7.2e-05	0.00112	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—ACP5—osteoporosis	7.2e-05	0.00112	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PKM—osteoporosis	7.18e-05	0.00111	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—FDPS—osteoporosis	7.18e-05	0.00111	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PNP—osteoporosis	7.08e-05	0.0011	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ATIC—osteoporosis	7.08e-05	0.0011	CbGpPWpGaD
Dorzolamide—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	7.08e-05	0.0011	CbGpPWpGaD
Dorzolamide—Vomiting—Conjugated Estrogens—osteoporosis	7.07e-05	0.000546	CcSEcCtD
Dorzolamide—Urticaria—Estradiol—osteoporosis	7.07e-05	0.000546	CcSEcCtD
Dorzolamide—Abdominal pain—Estradiol—osteoporosis	7.03e-05	0.000543	CcSEcCtD
Dorzolamide—Body temperature increased—Estradiol—osteoporosis	7.03e-05	0.000543	CcSEcCtD
Dorzolamide—Rash—Conjugated Estrogens—osteoporosis	7.01e-05	0.000541	CcSEcCtD
Dorzolamide—Dermatitis—Conjugated Estrogens—osteoporosis	7e-05	0.000541	CcSEcCtD
Dorzolamide—Headache—Conjugated Estrogens—osteoporosis	6.96e-05	0.000538	CcSEcCtD
Dorzolamide—CA5B—Metabolism—CYP27A1—osteoporosis	6.91e-05	0.00107	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CYP27A1—osteoporosis	6.91e-05	0.00107	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—TPI1—osteoporosis	6.87e-05	0.00106	CbGpPWpGaD
Dorzolamide—Nausea—Zoledronate—osteoporosis	6.86e-05	0.000529	CcSEcCtD
Dorzolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	6.82e-05	0.00106	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PGLS—osteoporosis	6.81e-05	0.00106	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GPD2—osteoporosis	6.81e-05	0.00106	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—IDH2—osteoporosis	6.81e-05	0.00106	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—ACP5—osteoporosis	6.72e-05	0.00104	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—ACP5—osteoporosis	6.72e-05	0.00104	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—TPI1—osteoporosis	6.69e-05	0.00104	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—TPI1—osteoporosis	6.69e-05	0.00104	CbGpPWpGaD
Dorzolamide—Nausea—Conjugated Estrogens—osteoporosis	6.6e-05	0.00051	CcSEcCtD
Dorzolamide—CA4—Metabolism—CA2—osteoporosis	6.55e-05	0.00102	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—OXCT1—osteoporosis	6.55e-05	0.00102	CbGpPWpGaD
Dorzolamide—Hypersensitivity—Estradiol—osteoporosis	6.55e-05	0.000506	CcSEcCtD
Dorzolamide—CA14—Metabolism—P4HB—osteoporosis	6.46e-05	0.001	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CYP27A1—osteoporosis	6.4e-05	0.000992	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—MGLL—osteoporosis	6.39e-05	0.00099	CbGpPWpGaD
Dorzolamide—Asthenia—Estradiol—osteoporosis	6.38e-05	0.000493	CcSEcCtD
Dorzolamide—CA14—Metabolism—GAPDH—osteoporosis	6.34e-05	0.000982	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—P4HB—osteoporosis	6.29e-05	0.000975	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—P4HB—osteoporosis	6.29e-05	0.000975	CbGpPWpGaD
Dorzolamide—Pruritus—Estradiol—osteoporosis	6.29e-05	0.000486	CcSEcCtD
Dorzolamide—CA2—Metabolism—OXCT1—osteoporosis	6.28e-05	0.000973	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—TPI1—osteoporosis	6.25e-05	0.000968	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—TPI1—osteoporosis	6.25e-05	0.000968	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PNP—osteoporosis	6.23e-05	0.000965	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ATIC—osteoporosis	6.23e-05	0.000965	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ACP5—osteoporosis	6.23e-05	0.000965	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—GAPDH—osteoporosis	6.18e-05	0.000957	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—GAPDH—osteoporosis	6.18e-05	0.000957	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—RAP1A—osteoporosis	6.17e-05	0.000957	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	6.16e-05	0.000954	CbGpPWpGaD
Dorzolamide—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	6.13e-05	0.000949	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—MGLL—osteoporosis	6.12e-05	0.000949	CbGpPWpGaD
Dorzolamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	6.09e-05	0.000944	CbGpPWpGaD
Dorzolamide—Diarrhoea—Estradiol—osteoporosis	6.09e-05	0.00047	CcSEcCtD
Dorzolamide—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	6.07e-05	0.000941	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—OXCT1—osteoporosis	6.02e-05	0.000933	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CA2—osteoporosis	6.02e-05	0.000933	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—RAP1A—osteoporosis	6.02e-05	0.000932	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—RAP1A—osteoporosis	6.02e-05	0.000932	CbGpPWpGaD
Dorzolamide—Dizziness—Estradiol—osteoporosis	5.88e-05	0.000454	CcSEcCtD
Dorzolamide—CA7—Metabolism—P4HB—osteoporosis	5.88e-05	0.00091	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—P4HB—osteoporosis	5.88e-05	0.00091	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—MGLL—osteoporosis	5.87e-05	0.00091	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—TPI1—osteoporosis	5.79e-05	0.000897	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—GAPDH—osteoporosis	5.77e-05	0.000894	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—GAPDH—osteoporosis	5.77e-05	0.000894	CbGpPWpGaD
Dorzolamide—Vomiting—Estradiol—osteoporosis	5.66e-05	0.000437	CcSEcCtD
Dorzolamide—CA5B—Metabolism—RAP1A—osteoporosis	5.62e-05	0.00087	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—RAP1A—osteoporosis	5.62e-05	0.00087	CbGpPWpGaD
Dorzolamide—Rash—Estradiol—osteoporosis	5.61e-05	0.000433	CcSEcCtD
Dorzolamide—Dermatitis—Estradiol—osteoporosis	5.6e-05	0.000433	CcSEcCtD
Dorzolamide—Headache—Estradiol—osteoporosis	5.57e-05	0.00043	CcSEcCtD
Dorzolamide—CA12—Metabolism—P4HB—osteoporosis	5.44e-05	0.000843	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—IDH2—osteoporosis	5.43e-05	0.000841	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—GAPDH—osteoporosis	5.34e-05	0.000828	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CA2—osteoporosis	5.3e-05	0.00082	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—OXCT1—osteoporosis	5.3e-05	0.00082	CbGpPWpGaD
Dorzolamide—Nausea—Estradiol—osteoporosis	5.28e-05	0.000408	CcSEcCtD
Dorzolamide—CA2—Metabolism—IDH2—osteoporosis	5.21e-05	0.000807	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—RAP1A—osteoporosis	5.2e-05	0.000806	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—MGLL—osteoporosis	5.16e-05	0.0008	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP27A1—osteoporosis	5.11e-05	0.000791	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—IDH2—osteoporosis	4.99e-05	0.000773	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—ENO1—osteoporosis	4.99e-05	0.000773	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ACP5—osteoporosis	4.97e-05	0.00077	CbGpPWpGaD
Dorzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	4.95e-05	0.000768	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PSMA2—osteoporosis	4.92e-05	0.000762	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PSMA5—osteoporosis	4.92e-05	0.000762	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP27A1—osteoporosis	4.9e-05	0.000758	CbGpPWpGaD
Dorzolamide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	4.89e-05	0.000758	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—ENO1—osteoporosis	4.86e-05	0.000754	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—ENO1—osteoporosis	4.86e-05	0.000754	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PSMA2—osteoporosis	4.79e-05	0.000743	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PSMA5—osteoporosis	4.79e-05	0.000743	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PSMA2—osteoporosis	4.79e-05	0.000743	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PSMA5—osteoporosis	4.79e-05	0.000743	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ACP5—osteoporosis	4.76e-05	0.000738	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP27A1—osteoporosis	4.69e-05	0.000727	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—TPI1—osteoporosis	4.62e-05	0.000715	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ACP5—osteoporosis	4.57e-05	0.000707	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—ENO1—osteoporosis	4.54e-05	0.000704	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—ENO1—osteoporosis	4.54e-05	0.000704	CbGpPWpGaD
Dorzolamide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.51e-05	0.000699	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PSMA2—osteoporosis	4.47e-05	0.000693	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PSMA5—osteoporosis	4.47e-05	0.000693	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PSMA2—osteoporosis	4.47e-05	0.000693	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PSMA5—osteoporosis	4.47e-05	0.000693	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—TPI1—osteoporosis	4.43e-05	0.000686	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—IDH2—osteoporosis	4.39e-05	0.00068	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—P4HB—osteoporosis	4.34e-05	0.000673	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GAPDH—osteoporosis	4.26e-05	0.00066	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—TPI1—osteoporosis	4.24e-05	0.000658	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ENO1—osteoporosis	4.21e-05	0.000652	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—P4HB—osteoporosis	4.16e-05	0.000645	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—RAP1A—osteoporosis	4.15e-05	0.000643	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PSMA2—osteoporosis	4.15e-05	0.000642	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PSMA5—osteoporosis	4.15e-05	0.000642	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP27A1—osteoporosis	4.13e-05	0.000639	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	4.12e-05	0.000638	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GAPDH—osteoporosis	4.09e-05	0.000633	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	4.06e-05	0.000629	CbGpPWpGaD
Dorzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.02e-05	0.000622	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ACP5—osteoporosis	4.01e-05	0.000622	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	4.01e-05	0.000621	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—P4HB—osteoporosis	3.99e-05	0.000618	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CYP19A1—osteoporosis	3.99e-05	0.000618	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—RAP1A—osteoporosis	3.98e-05	0.000616	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GAPDH—osteoporosis	3.92e-05	0.000607	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.9e-05	0.000605	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CYP19A1—osteoporosis	3.89e-05	0.000602	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CYP19A1—osteoporosis	3.89e-05	0.000602	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—RAP1A—osteoporosis	3.81e-05	0.000591	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—TPI1—osteoporosis	3.73e-05	0.000578	CbGpPWpGaD
Dorzolamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.66e-05	0.000567	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CYP19A1—osteoporosis	3.63e-05	0.000562	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CYP19A1—osteoporosis	3.63e-05	0.000562	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—P4HB—osteoporosis	3.51e-05	0.000544	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GAPDH—osteoporosis	3.44e-05	0.000533	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CYP19A1—osteoporosis	3.36e-05	0.000521	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ENO1—osteoporosis	3.36e-05	0.00052	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—RAP1A—osteoporosis	3.35e-05	0.00052	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PSMA2—osteoporosis	3.31e-05	0.000512	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PSMA5—osteoporosis	3.31e-05	0.000512	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—ADCY5—osteoporosis	3.26e-05	0.000505	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—GPX1—osteoporosis	3.25e-05	0.000503	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	3.23e-05	0.000501	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ENO1—osteoporosis	3.22e-05	0.000498	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	3.19e-05	0.000494	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—ADCY5—osteoporosis	3.18e-05	0.000492	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—ADCY5—osteoporosis	3.18e-05	0.000492	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PSMA2—osteoporosis	3.17e-05	0.000491	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PSMA5—osteoporosis	3.17e-05	0.000491	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—GPX1—osteoporosis	3.17e-05	0.000491	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—GPX1—osteoporosis	3.17e-05	0.000491	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ENO1—osteoporosis	3.08e-05	0.000478	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PSMA2—osteoporosis	3.04e-05	0.000471	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PSMA5—osteoporosis	3.04e-05	0.000471	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.04e-05	0.00047	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—MTHFR—osteoporosis	3e-05	0.000465	CbGpPWpGaD
Dorzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.98e-05	0.000461	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—ADCY5—osteoporosis	2.97e-05	0.00046	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—ADCY5—osteoporosis	2.97e-05	0.00046	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.96e-05	0.000458	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—GPX1—osteoporosis	2.96e-05	0.000458	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—GPX1—osteoporosis	2.96e-05	0.000458	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—MTHFR—osteoporosis	2.92e-05	0.000453	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—MTHFR—osteoporosis	2.92e-05	0.000453	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ADCY5—osteoporosis	2.75e-05	0.000426	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—GPX1—osteoporosis	2.74e-05	0.000424	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—MTHFR—osteoporosis	2.73e-05	0.000423	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—MTHFR—osteoporosis	2.73e-05	0.000423	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ENO1—osteoporosis	2.71e-05	0.00042	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP19A1—osteoporosis	2.68e-05	0.000416	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PSMA2—osteoporosis	2.67e-05	0.000414	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PSMA5—osteoporosis	2.67e-05	0.000414	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP19A1—osteoporosis	2.57e-05	0.000398	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—MTHFR—osteoporosis	2.53e-05	0.000392	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP19A1—osteoporosis	2.47e-05	0.000382	CbGpPWpGaD
Dorzolamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.41e-05	0.000374	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—POMC—osteoporosis	2.4e-05	0.000372	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.36e-05	0.000366	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—IL6—osteoporosis	2.35e-05	0.000364	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—POMC—osteoporosis	2.34e-05	0.000362	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—POMC—osteoporosis	2.34e-05	0.000362	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ADCY5—osteoporosis	2.19e-05	0.00034	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GPX1—osteoporosis	2.18e-05	0.000338	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—POMC—osteoporosis	2.18e-05	0.000338	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—POMC—osteoporosis	2.18e-05	0.000338	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP19A1—osteoporosis	2.17e-05	0.000336	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.13e-05	0.000331	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.1e-05	0.000326	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ADCY5—osteoporosis	2.1e-05	0.000326	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GPX1—osteoporosis	2.09e-05	0.000324	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—POMC—osteoporosis	2.02e-05	0.000313	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—MTHFR—osteoporosis	2.02e-05	0.000312	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ADCY5—osteoporosis	2.01e-05	0.000312	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.01e-05	0.000312	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GPX1—osteoporosis	2.01e-05	0.000311	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—POMC—osteoporosis	1.94e-05	0.000301	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—MTHFR—osteoporosis	1.93e-05	0.000299	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—MTHFR—osteoporosis	1.85e-05	0.000287	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PKM—osteoporosis	1.83e-05	0.000284	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—FDPS—osteoporosis	1.83e-05	0.000284	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ADCY5—osteoporosis	1.77e-05	0.000274	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GPX1—osteoporosis	1.76e-05	0.000273	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PGLS—osteoporosis	1.74e-05	0.000269	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GPD2—osteoporosis	1.74e-05	0.000269	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—MTHFR—osteoporosis	1.63e-05	0.000252	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—POMC—osteoporosis	1.61e-05	0.00025	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ATIC—osteoporosis	1.59e-05	0.000246	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PNP—osteoporosis	1.59e-05	0.000246	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—POMC—osteoporosis	1.55e-05	0.000239	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—POMC—osteoporosis	1.48e-05	0.00023	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CA2—osteoporosis	1.35e-05	0.000209	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—OXCT1—osteoporosis	1.35e-05	0.000209	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MGLL—osteoporosis	1.32e-05	0.000204	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—POMC—osteoporosis	1.3e-05	0.000202	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—POMC—osteoporosis	1.28e-05	0.000199	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.24e-05	0.000192	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PKM—osteoporosis	1.21e-05	0.000187	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—FDPS—osteoporosis	1.21e-05	0.000187	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GPD2—osteoporosis	1.15e-05	0.000178	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PGLS—osteoporosis	1.15e-05	0.000178	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—IDH2—osteoporosis	1.12e-05	0.000174	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.05e-05	0.000163	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ATIC—osteoporosis	1.05e-05	0.000162	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PNP—osteoporosis	1.05e-05	0.000162	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ACP5—osteoporosis	1.02e-05	0.000159	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.01e-05	0.000157	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TPI1—osteoporosis	9.52e-06	0.000148	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—P4HB—osteoporosis	8.95e-06	0.000139	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CA2—osteoporosis	8.92e-06	0.000138	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—OXCT1—osteoporosis	8.92e-06	0.000138	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GAPDH—osteoporosis	8.79e-06	0.000136	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MGLL—osteoporosis	8.69e-06	0.000135	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—RAP1A—osteoporosis	8.56e-06	0.000133	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.47e-06	0.000116	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—IDH2—osteoporosis	7.39e-06	0.000114	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP27A1—osteoporosis	6.95e-06	0.000108	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ENO1—osteoporosis	6.92e-06	0.000107	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PSMA2—osteoporosis	6.82e-06	0.000106	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PSMA5—osteoporosis	6.82e-06	0.000106	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ACP5—osteoporosis	6.76e-06	0.000105	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TPI1—osteoporosis	6.28e-06	9.73e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—P4HB—osteoporosis	5.91e-06	9.15e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GAPDH—osteoporosis	5.8e-06	8.98e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—RAP1A—osteoporosis	5.65e-06	8.75e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP19A1—osteoporosis	5.53e-06	8.57e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ENO1—osteoporosis	4.56e-06	7.07e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ADCY5—osteoporosis	4.52e-06	7e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GPX1—osteoporosis	4.5e-06	6.98e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PSMA2—osteoporosis	4.5e-06	6.97e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PSMA5—osteoporosis	4.5e-06	6.97e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MTHFR—osteoporosis	4.16e-06	6.44e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP19A1—osteoporosis	3.65e-06	5.65e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—POMC—osteoporosis	3.32e-06	5.15e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ADCY5—osteoporosis	2.98e-06	4.62e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GPX1—osteoporosis	2.97e-06	4.6e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MTHFR—osteoporosis	2.74e-06	4.25e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—POMC—osteoporosis	2.19e-06	3.4e-05	CbGpPWpGaD
